Katherine Stueland, CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. (WGS), sold 3,306 shares at $94.00 ($311K) on 2026-01-29, disclosed to the SEC on 2026-02-02.
Open-market sale of $311k WGS by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.00 | 1,653 | $155K | 50.0% |
| 2 | $94.00 | 1,653 | $155K | 50.0% |
| Total | $94.00 avg | 3,306 | $311K | 100% |
| Filing → |
| WGS | SELL | 2026-06-18 | $638K | — | Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |